InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,030.43
(
0.04%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: ariadndndough post# 5241

Monday, 01/24/2011 8:04:06 AM

Monday, January 24, 2011 8:04:06 AM

Post# of 80490
My understanding is that a priority review is given to drugs that offer major advances in treatment, or provide a treatment where no adequate therapy exists. Based on this, rida certainly seems to qualify but it's up to Merck to file the request. If granted, a priority review means that the time it takes the FDA to review the rida application is potentially reduced to 6 months from the 10 months for a standard review.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up